Biologically active peptides and compositions, their use
    1.
    发明授权
    Biologically active peptides and compositions, their use 失效
    生物活性肽和组合物,其用途

    公开(公告)号:US6153590A

    公开(公告)日:2000-11-28

    申请号:US930584

    申请日:1998-02-02

    摘要: Compounds of general formula I ##STR1## wherein: R.sub.1 and R.sub.70 independently represent a hydrogen atom or an optionally substituted alkyl or acyl group; R.sub.2 represents a hydrogen atom or an optionally substituted alkyl or acyl group or is absent when R.sub.6 represents a group --CH.dbd. as hereinafter described; R.sub.73 represents a hydrogen atom or an optional substituent or is absent when R.sub.6 represents a methylene group or a group --CH.dbd. as hereinafter described; Y represents an optional substituent; n represents 0, 1, 2, 3, or 4; R.sub.3 represents a hydrogen atom, or an optionally substituted alkyl group; R.sub.74 represents a hydrogen atom, a hydroxy group or an optionally substituted alkyl or acyl group; R.sub.7 represents a hydrogen atom or an alkyl group; R.sub.75 represents an optionally substituted alkyl group; and i) R.sub.6 and R.sub.71 independently represent a hydrogen atom or an optionally substituted alkyl or acyl group; and R.sub.72 represents a hydrogen atom; or ii) R.sub.71 represents a hydrogen atom or an optionally susbtituted alkyl or acyl group and R.sub.72 represents a hydrogen atom or R.sub.71 and R.sub.72 are joined together such that a double bond is formed between the carbon atoms to which they are attached; and R.sub.6 represents an optionally substituted methylene group bonded to the indole moiety thereby forming a tricyclic moiety; or R.sub.6 represents an optionally substituted group --CH.dbd. bonded to the indole moiety thereby to form an aromatic tricyclic moiety; for use in therapy and as antimitotic reagents are described.

    摘要翻译: PCT No.PCT / GB96 / 00942 Sec。 371日期1998年2月2日 102(e)1998年2月2日PCT 1996年4月22日PCT PCT。 出版物WO96 / 33211 日期:1996年10月24日通式I化合物其中:R 1和R 70独立地表示氢原子或任选取代的烷基或酰基; R2表示氢原子或任选取代的烷基或酰基,或当R6表示基团-CH =时不存在,如下所述; 当R 6表示亚甲基或-CH =如下所述时,R 73表示氢原子或任选的取代基或不存在; Y表示任选的取代基; n表示0,1,2,3或4; R3表示氢原子或任选取代的烷基; R 74表示氢原子,羟基或任选取代的烷基或酰基; R7表示氢原子或烷基; R75表示任选取代的烷基; 和i)R 6和R 71独立地表示氢原子或任选取代的烷基或酰基; R 72表示氢原子; 或ii)R 71表示氢原子或任选取代的烷基或酰基,R 72表示氢原子或R 71和R 72连接在一起,使得在它们所连接的碳原子之间形成双键; 并且R 6表示与吲哚部分键合的任选取代的亚甲基,从而形成三环部分; 或R6表示与吲哚部分键合的任选取代的基团-CH =,从而形成芳族三环部分; 用于治疗和用作抗有益剂的试剂。

    Estradienes
    10.
    发明授权
    Estradienes 失效
    埃斯特丹人

    公开(公告)号:US06458778B1

    公开(公告)日:2002-10-01

    申请号:US09049485

    申请日:1998-03-27

    IPC分类号: A61K3156

    CPC分类号: C07J1/00

    摘要: This invention provides estra-5(10),7-dien-3&bgr;-ol-17-one or a pharmaceutically acceptable salt of its 3-sulfate ester, estra-5(10),7-dien-3&bgr;-ol-17-one 3-glucuronide or a pharmaceutically acceptable salt thereof, estra-5(10),7-dien-3&agr;-ol-17-one or a pharmaceutically acceptable salt of its 3-sulfate ester, estra-5(10),7-dien-3&bgr;-ol-17-one 3-glucuronide or a pharmaceutically acceptable salt thereof, estra-5(10),7-dien-3&bgr;-ol-17-one 3-alkali metal salt, and estra-5(10),7-dien-3&agr;-ol-17-one 3-alkali metal salt which are useful as estrogenic agents.

    摘要翻译: 本发明提供雌甾-5(10),7-二烯-3β-醇-17-或其3-硫酸酯,雌-5(10),7-二烯-3β-醇-17-酮的药学上可接受的盐, 一种3-葡糖苷酸或其药学上可接受的盐,estra-5(10),7-二烯-3α-醇-17-或其3-硫酸酯的药学上可接受的盐,estra-5(10),7- 二烯-3β-醇-17-酮3-葡糖苷酸或其药学上可接受的盐,雌-5(10),7-二烯-3β-醇-17-酮3-碱金属盐和雌甾-5(10) ,7-二烯-3α-醇-17-酮3-碱金属盐,其可用作雌激素剂。